Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria
- PMID: 22286802
Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria
Abstract
Objective: As increased frequency of gonadotrophin-releasing hormone (GnRH) pulses is characteristic for polycystic ovary syndrome (PCOS), we assessed gonadotrophin response to GnRH in women with PCOS with normal and raised androgens and in regularly menstruating controls.
Design, patients and methods: The study involved 155 subjects: PCOS, n=121, age (mean±SD) 24.8±5.4 yrs, BMI 24.5±6.0 kg/m2, all with oligo-/amenorrhoea and PCO morphology, and 34 controls. Gonadotrophins were measured in early follicular phase after GnRH stimulation (0, 30 and 60 minutes).
Results: Fifty four (41.9%) women with PCOS had androgens (testosterone, androstendione, dihydroepiandrosterone sulphate) within the reference range, and would fulfil the "Rotterdam", but not the Androgen Excess Society PCOS criteria. Baseline and stimulated LH concentrations were higher in PCOS (9.09±5.56 vs 4.83±1.71 IU/l, 35.48±31.4 vs 16.30±6.68 IU/l, 33.86±31.8 vs 13.45±5.2 IU/l, at 0, 30 and 60 min post GnRH, respectively, p<0.0001). An LH/FSH ratio in PCOS increased further after GnRH stimulation. ROC analysis revealed that LH30min/FSH30min >2.11 or LH60min/FSH60min >1.72 had 78.3% and 87.5% sensitivity and 81.7% and 81.3% specificity for diagnosis of PCOS. Both baseline and GnRH-stimulated LH and FSH concentrations were similar in women with PCOS and raised androgens and with androgens within the reference range (p=0.71 and p=0.20 for LH and FSH, respectively).
Conclusions: Regardless of their androgen status, women with PCO morphology and oligo-/amenorrhoea have higher baseline and GnRH-stimulated LH concentrations and higher GnRH-stimulated LH/FSH ratio than controls, suggestive of similar underlying mechanism accounting for menstrual irregularities. These observations support validity of PCOS diagnostic criteria based on the Rotterdam consensus.
Similar articles
-
The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).Endokrynol Pol. 2011;62(2):120-8. Endokrynol Pol. 2011. PMID: 21528473
-
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7. doi: 10.1111/j.1365-2265.2007.02764.x. Clin Endocrinol (Oxf). 2007. PMID: 17371468
-
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12. Arch Gynecol Obstet. 2006. PMID: 16691383
-
Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.Semin Reprod Med. 2007 Sep;25(5):352-9. doi: 10.1055/s-2007-984741. Semin Reprod Med. 2007. PMID: 17710731 Review.
-
Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.Semin Reprod Med. 2002 Nov;20(4):317-26. doi: 10.1055/s-2002-36706. Semin Reprod Med. 2002. PMID: 12536355 Review.
Cited by
-
How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models.Arch Med Sci. 2019 May;15(3):613-618. doi: 10.5114/aoms.2019.82672. Epub 2019 Jan 30. Arch Med Sci. 2019. PMID: 31110526 Free PMC article.
-
Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.J Endocr Soc. 2020 Nov 5;5(1):bvaa172. doi: 10.1210/jendso/bvaa172. eCollection 2021 Jan 1. J Endocr Soc. 2020. PMID: 33324863 Free PMC article. Review.
-
Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS).Clin Endocrinol (Oxf). 2021 Aug;95(2):239-252. doi: 10.1111/cen.14402. Epub 2021 Jan 19. Clin Endocrinol (Oxf). 2021. PMID: 33354766 Free PMC article. Review.
-
Medical hypothesis: can gonadotropins influence thyroid volume in women with PCOS?Thyroid Res. 2012 Nov 29;5(1):17. doi: 10.1186/1756-6614-5-17. Thyroid Res. 2012. PMID: 23194382 Free PMC article.
-
Quercetin and polycystic ovary syndrome.Front Pharmacol. 2022 Dec 16;13:1006678. doi: 10.3389/fphar.2022.1006678. eCollection 2022. Front Pharmacol. 2022. PMID: 36588716 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials